The Gross Margin of Daewoong Pharma (069620.KS) is 51.60%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 51.60% |
| 2023-12-31 | 50.04% |
| 2022-12-31 | 49.91% |
| 2021-12-31 | 47.23% |
| 2020-12-31 | 42.35% |
| 2019-12-31 | 42.96% |
| 2018-12-31 | 39.75% |
| 2017-12-31 | 42.38% |
| 2016-12-31 | 42.28% |
| 2015-12-31 | 36.04% |